Valo to develop pancoronavirus vaccine

By The Science Advisory Board staff writers

April 27, 2020 -- Valo Therapeutics announced that it is working on the development of a potential COVID-19 vaccine with applications across future pandemics.

The company will use its peptide-coated conditionally replicating adenovirus (PeptiCRAd) technology to coat an adenovirus vector, engineered to express coronavirus spike proteins with human leukocyte antigen-matched peptides that boost CD8+ T-cell immune responses. Both components had to be tested individually in the past, and the company believes that it will be much quicker to manufacture clinical-grade peptides for coating an adenoviral vector rather than reengineering a new virus. Moreover, this approach allows flexibility and rapid clinical testing if a new coronavirus strain emerges.

A T-cell vaccine could be useful, according to the company, because coronaviruses produce neutralizing antibodies that require cell-mediated clearance. The company hopes that the combination of adenoviral vectors will produce strong T-cell mediated immune responses and that the SARS-CoV-2 spike proteins will produce antibody-mediated immune responses. The additional coating with selected peptides will serve to further boost the cell-mediated response and broaden the immune targets.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here